ACR Appropriateness Criteria ® Post-treatment Follow-up Prostate Cancer

Author:

Froemming Adam T.,Verma Sadhna,Eberhardt Steven C.,Oto Aytekin,Alexander Lauren F.,Allen Brian C.,Coakley Fergus V.,Davis Brian J.,Fulgham Pat F.,Hosseinzadeh Keyanoosh,Porter Christopher,Sahni V. Anik,Schuster David M.,Showalter Timothy N.,Venkatesan Aradhana M.,Wang Carolyn L.,Remer Erick M.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference127 articles.

1. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy;Choueiri;J Urol,2008

2. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience;Han;Urol Clin North Am,2001

3. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group;Teeter;Urology,2013

4. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

5. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. Version 3.2016. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed December 4, 2017.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3